Federal contract award
W81K0022F0160
COAGULATION ANALYZER & REAGENTS - FSS CONTRACT - V797D-60637
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRC0 WEST |
| NAICS | 334516 — Analytical Laboratory Instrument Manufacturing |
| PSC | 6630 — Chemical Analysis Instruments |
| Parent award / vehicle | V797D60637 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.1M |
| Current contract value | $1.3M |
| Potential contract value / ceiling | $1.3M |
| Start date | Oct 1, 2022 |
| Current end date | Sep 30, 2027 |
| Potential end date | Sep 30, 2027 |
| Latest award activity | Apr 9, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 15 of 15 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 9, 2026 | P00014 | $0 | PURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT, W81K00-22-F-0160 WITH ORTHO CLINICAL DIAGNOSTICS, INC., INC IS HEREBY EXTENDED FOR THE PERIOD 01 OCTOBER 2026 - 30 SEPTEMBER 2027 (OPTION YEAR 4). |
| Feb 25, 2026 | P00013 | $5.3K | THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO ADD MTS ANTI-C (MONOCLONAL) CARDS 1X20 AND MTS ANTI-E (MONOCLONAL) CARDS 1X20 TO THE EXISTING ORTHO VISION DELIVERY ORDER FOR OPTION YEAR 3 AND 4 ON SUB-CLINS 3001AY, 3001AZ, 4001AY AND 4001AZ. |
| Dec 10, 2025 | P00012 | $0 | IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR DELIVERY ORDER W81K00-22-F-0160 FOR THE PERIOD OF 1 OCTOBER 2025 - 30 SEPTEMBER 2026. |
| Dec 3, 2025 | P00011 | $255.9K | IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR DELIVERY ORDER W81K00-22-F-0160 FOR THE PERIOD OF 1 OCTOBER 2025 - 30 SEPTEMBER 2026. |
| Aug 14, 2025 | P00010 | $0 | PURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT, W81K00-22-F-0160 WITH ORTHO CLINICAL DIAGNOSTICS, INC., INC IS HEREBY EXTENDED FOR THE PERIOD 01 OCTOBER 2025 - 30 SEPTEMBER 2026 (OPTION YEAR 3). |
| Feb 26, 2025 | P00009 | $0 | MTS A/B/D MONO & REVERSE GRP C |
| Feb 25, 2025 | P00008 | $5.2K | MTS A/B/D MONO & REVERSE GRP C - DECREASE & ADD NEW REAGENT. |
| Nov 27, 2024 | P00007 | $267.4K | MTS A/B/D MONO & REVERSE GRP C - FY25 FUNDING MODIFICATION |
| Aug 9, 2024 | P00006 | $0 | MTS A/B/D MONO & REVERSE GRP C - FY25 OPTION YEAR |
| Aug 2, 2024 | P00005 | $0 | MTS A/B/D MONO & REVERSE GRP C - ADD & DECREASE OF QUANTITIES FOR REAGENTS. |
| Nov 15, 2023 | P00004 | $271.1K | MTS A/B/D MONO & REVERSE GRP C - FUNDING MODIFICATION |
| May 9, 2023 | P00003 | $0 | MTS A/B/D MONO & REVERSE GRP C - EXERCISE THE FY24 OPTION YEAR. |
| Mar 23, 2023 | P00002 | $64.7K | MTS A/B/D MONO & REVERSE GRP C - ADD IMMUNOHEMATOLOGY TESTING REAGENTS. |
| Nov 3, 2022 | P00001 | $206.4K | MTS A/B/D MONO & REVERSE GRP C - FY23 FUNDING ACTION |
| Sep 16, 2022 | 0 | $0 | COAGULATION ANALYZER & REAGENTS - FSS CONTRACT - V797D-60637 |
Estimated positioning window
Nov 1, 2026 – Mar 30, 2027
Recompete signal: . Rule-based research score; positioning dates are estimates.
85/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 85/100. Available recorded signals: 80 points.
- Contract end 2027-09-30 (333 days from calculation)
- +35 points
- 4 historical awards in this buyer and category group
- +15 points
- 15 recorded award transactions
- +10 points
- Latest award action: 2026-04-09
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.